10-K/A
 FORM 10-K/A

 UNITED STATES

 SECURITIES AND EXCHANGE COMMISSION

 WASHINGTON, D.C. 20549

 FORM 10-K/A

 (Amendment No. 2)

 ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)

 OF THE SECURITIES EXCHANGE ACT OF 1934

 For the fiscal year ended August 31, 2024

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)

 OF THE SECURITIES EXCHANGE ACT OF 1934

 For the transition period from ___________ to ___________

 Commission file number 333-127953

 SOLARWINDOW TECHNOLOGIES, INC.

 (Exact name of registrant as specified in its charter)

 Nevada

 (State or other jurisdiction of incorporation or organization)

 59-3509694

 (I.R.S. Employer Identification No.)

 9375 E. Shea Blvd., Suite 107-B

 Scottsdale, Arizona

 85260

 (Address of principal executive offices)

 (Zip Code)

 (800) 213-0689

 (Registrant's telephone number, including area code)

 Securities registered pursuant to Section 12(b) of the Act: None

 Title of each class

 Trading Symbol(s)

 Name of each exchange on which registered

 N/A

 N/A

 N/A

 Securities registered pursuant to Section 12(g) of the Act: None

 Indicate by check mark if the registrant is a well-known seasoned issuer,
as defined in Rule 405 of the Securities Act. Yes No

 Indicate by check mark if the registrant is not required to file reports
pursuant to Section 13 or 15(d) of the Act.

 Yes No

 Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter
period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 Yes No

 Indicate by check mark whether the registrant has submitted
electronically every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405
of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes No

 Indicate by check mark whether the registrant is a large accelerated filer,
an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large
accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company"
in Rule 12b-2 of the Exchange Act.

 Large accelerated filer

 Accelerated filer

 Non-accelerated filer

 Smaller reporting company

 Emerging growth company

 If an emerging growth company, indicate by check mark if
the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act.

 Indicate by check mark whether the registrant has filed a report on
and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under
Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting fi rm that prepared or issued its
audit report.

 If securities are registered pursuant to Section 12(b) of the Act, indicate
by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously
issued financial statements.

 Indicate by check mark whether any of those error corrections are restatements
that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during
the relevant recovery period pursuant to §240.10D-1(b).

 Indicate by check mark whether the registrant is a shell
company (as defined in Rule 12b-2 of the Exchange Act.). Yes No

 The aggregate market value of SolarWindow common stock held
by non-affiliates of the registrant as of the last day of our most recently completed second quarter on February 29, 2024, was $6,065,000.

 As of November 19, 2024, 53,198,399 shares of common stock, par value
$0.001, were outstanding.

 Documents incorporated by reference: None.

 EXPLANATORY NOTE

 SolarWindow Technologies, Inc. (the "Company") is filing this
Amendment No. 2 on Form 10-K/A (this "Amendment No. 2") to amend the Company's Annual Report on Form 10-K for the year
ended August 31, 2024, which was initially filed with the U.S. Securities and Exchange Commission (the "SEC") on November
20, 2024 as amended via Amendment No. 1 filed with the SEC on December 5, 2024 (the "Original 2024 Form 10-K as Amended").
The purpose of this Amendment No. 2 is to expand disclosure related to our majority shareholder under Item 1A, Risk Factors.

 Except as otherwise expressly noted herein, this Amendment No. 2 does not
modify or update in any way the financial position, results of operations, cash flows, or other disclosure in, or exhibits to, the Original
Form 10-K as Amended, nor does it reflect events occurring after the filing of the Original Form 10-K. Accordingly, this Amendment No.
2 should be read in conjunction with the Original Form 10-K as Amended.

 Pursuant to Rule 12b-15 under the Securities Exchange Act of 1934, as amended
(the "Exchange Act"), this Amendment No. 2 also contains new certifications pursuant to Sections 302 of the Sarbanes-Oxley
Act of 2002, which are attached hereto as Exhibits 31.1 and 32.1. Because no financial statements have been included in this Amendment
No. 2 and this Amendment No. 2 does not contain or amend any disclosure with respect to Items 307 and 308 of Regulation S-K under the
Exchange Act, paragraphs 3, 4 and 5 of the certifications have been omitted.

 Item
 1A. Risk Factors

 Kalen Capital Corporation ("KCC"), a private corporation
solely owned by Mr. Harmel S. Rayat, beneficially owns approximately 72.68% of our issued and outstanding stock when giving effect to
derivative securities owned by KCC. This ownership interest may preclude you from influencing significant corporate decisions.

 As of the date of this annual report, KCC beneficially owns 50,705,598
shares (inclusive of 16,566,667 shares issuable upon exercise of outstanding warrants and 34,138,931 shares of common stock issued and
outstanding), or approximately 72.68% of our outstanding common stock, on a fully diluted basis. Mr. Rayat has voting and disposition
authority over these shares.

 As previously reported by the Company on Form 8-K
dated, on February 28, 2024, available at
Mr. Rayat and the SEC jointly and voluntarily entered into a settlement agreement resolving the claims asserted against Mr. Rayat in the
SEC's amended complaint as filed in Securities and Exchange Commission v. Harmel S. Rayat, RenovaCare, Inc., Jatinder Bhogal,
Jeetenderjit Singh Sidhu, and Sharon Fleming, No. 1:21-cv-04777 (S.D.N.Y.) (the " SEC Case "). Pursuant to the
agreed to terms of the settlement Mr. Rayat, on a "no admit no deny" basis, consented to the entry of a judgment, issued on
February 27, 2024, by the US District Court for the Southern District of New York, (the " Judgment ") permanently enjoining
him from violating Section 17(a) of the Securities Act of 1933 (" Securities Act ") and Sections 10(b) and 20(b) of the
Securities Exchange Act of 1934 (" Exchange Act "), and Rule 10b-5 thereunder; prohibiting him from acting as an officer
or director of a public company; barring him from participating in the offering of any penny stock; and ordering him to pay disgorgement
of $1,270,352, prejudgment interest of $207,656, and a civil penalty of $1,270,352.

 Notwithstanding the issuance of the Judgment, Mr.
Rayat continues to have voting and disposition authority over the shares of the Company's common stock owned by KCC; accordingly,
Mr. Rayat can exercise control over matters requiring stockholder approval, including the election of directors and approval of significant
corporate transactions, and will have significant control over our management and policies. Mr. Rayat's interests may be different from
yours. For example, he may support proposals and actions with which you may disagree, or which are not in your interest. This concentration
of ownership could delay, prevent, or cause a change in control should Mr. Rayat sell all or a portion of his shares of our company or
otherwise discourage a potential acquirer from attempting to obtain control of our company, which in turn could reduce the price of our
common stock, possibly cause acceleration of vesting of outstanding options, result in limits to the utilization of our net operating
loss, and may adversely affect your investment. In addition, Mr. Rayat could use his voting influence to maintain our existing management
and Board of Directors in office, or support or reject other management and Board members proposals that are subject to stockholder approval,
such as the adoption of employee stock plans and significant unregistered and registered financing transactions.

 The Company was not a party to, or defendant in, the
SEC Case. The foregoing summary of the Judgement entered in the SEC Case is based upon the Company's review and understanding of
the filed documents, including, but not limited to the Judgment and the SEC Litigation Release No. 25945 / February 27, 2024 Securities
and Exchange Commission v. Harmel S. Rayat, RenovaCare, Inc., Jatinder Bhogal, Jeetenderjit Singh Sidhu, and Sharon Fleming, No.
1:21-cv-04777 (S.D.N.Y.) (the "SEC Litigation Release"), pertaining to Messrs. Rayat and is qualified in its entirety by reference
to the SEC Litigation Release. The SEC Litigation Release may be found on the SEC website at:

 ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES.

 (b)

 Exhibit Index

 The following is a list of exhibits filed as part
of this Form 10-K/A.

 Exhibit No.

 Description
 of Exhibit

 31.1

 Certification of the Acting Principal Executive Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*

 31.2

 Certification of the Principal Financial Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, As Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*

 *Filed herewith this Amendment No.2.

 SIGNATURES

 Pursuant to the requirements
of Sections 13 or 15(d) of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.

 SolarWindow Technologies, Inc.

 By:

 /S/ Amit Singh

 Amit Singh

 Chief Executive Officer (Principal Executive Officer)

 Date:

 March 27, 2025

 By:

 /S/ Justin Frere, CPA

 Justin Frere, CPA

 Interim Chief Financial Officer

 (Principal Financial Officer and Principal Accounting Officer)

 Date:

 March 27, 2025